BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15533468)

  • 1. Self-report of prostatitis and its risk factors in a random sample of middle-aged men.
    Rothman I; Stanford JL; Kuniyuki A; Berger RE
    Urology; 2004 Nov; 64(5):876-9; discussion 879-80. PubMed ID: 15533468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men.
    Sarma AV; McLaughlin JC; Wallner LP; Dunn RL; Cooney KA; Schottenfeld D; Montie JE; Wei JT
    J Urol; 2006 Sep; 176(3):1108-13. PubMed ID: 16890703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates and prevalence of prostatitis in a large community-based cohort of older men.
    Daniels NA; Ewing SK; Zmuda JM; Wilt TJ; Bauer DC;
    Urology; 2005 Nov; 66(5):964-70. PubMed ID: 16286104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses.
    Clemens JQ; Meenan RT; O'Keeffe Rosetti MC; Kimes T; Calhoun EA
    J Urol; 2007 Oct; 178(4 Pt 1):1333-7. PubMed ID: 17706722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
    Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
    Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatitis as a risk factor for prostate cancer.
    Roberts RO; Bergstralh EJ; Bass SE; Lieber MM; Jacobsen SJ
    Epidemiology; 2004 Jan; 15(1):93-9. PubMed ID: 14712152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
    Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and the risk of prostate cancer.
    Porter MP; Stanford JL
    Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of self-report versus chart-based prostate cancer, PSA, DRE and urinary symptoms.
    Sayre EC; Bunting PS; Kopec JA
    Can J Urol; 2009 Feb; 16(1):4463-71. PubMed ID: 19222884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community.
    Clemens JQ; Meenan RT; O'Keeffe Rosetti MC; Gao SY; Calhoun EA
    J Urol; 2005 Dec; 174(6):2319-22. PubMed ID: 16280832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset prostate cancer: predictors of clinical grade.
    Kotsis SV; Spencer SL; Peyser PA; Montie JE; Cooney KA
    J Urol; 2002 Apr; 167(4):1659-63. PubMed ID: 11912383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of prostatitis-like symptoms in China.
    Liang CZ; Li HJ; Wang ZP; Xing JP; Hu WL; Zhang TF; Ge WW; Hao ZY; Zhang XS; Zhou J; Li Y; Zhou ZX; Tang ZG; Tai S
    J Urol; 2009 Aug; 182(2):558-63. PubMed ID: 19524948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasectomy and prostate cancer.
    Lesko SM; Louik C; Vezina R; Rosenberg L; Shapiro S
    J Urol; 1999 Jun; 161(6):1848-52; discussion 1852-3. PubMed ID: 10332451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
    Chan JM; Latini DM; Cowan J; Duchane J; Carroll PR
    Cancer Causes Control; 2005 Sep; 16(7):789-97. PubMed ID: 16132789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital and urinary tract diseases and prostate cancer risk.
    Pelucchi C; Talamini R; Negri E; Franceschi S; La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):254-7. PubMed ID: 16679869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms.
    Sutcliffe S; Giovannucci E; De Marzo AM; Willett WC; Platz EA
    Am J Epidemiol; 2005 Nov; 162(9):898-906. PubMed ID: 16177142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-specific granulomatous prostatitis. Relationship and differential diagnosis with prostatic cancer].
    Osca García JM; Alfaro Ferreres L; Vera Donoso CD; Ruíz Cerdá JL; Martínez Jabaloyas JM; Jiménez Cruz JF
    Actas Urol Esp; 1994 Apr; 18(4):287-90. PubMed ID: 7976715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.